Notice of Intent to Sole Source – American Association of Blood Banks for Specialized Blood Products Annual Accreditation Fee 26-000709
Summary
AI-generated · Feb 27, 2026The Department of Transfusion Medicine seeks to obtain annual accreditation fees from the American Association of Blood Banks (AABB) to cover accreditation assessments for specialized blood products; total costs will vary based on the number of accreditation types requested, the annual number of products manufactured, and the product types produced, with current pricing shown as a placeholder until the official invoice is issued. This is a sole-source acquisition.
AABB is the only known organization authorized to assess compliance with its published standards, and accreditation through AABB is required for member organizations. AABB provides inspection services required by HHS/CMS to obtain and maintain a certificate of compliance necessary to issue clinical test results, with the tests needing to comply with CLIA requirements. Vendors that can provide equivalent accreditation and inspection services may submit a capability statement for consideration; the government will review submissions to determine if a competitive acquisition is warranted, and the decision to compete remains at the government’s discretion.
Notice of Intent to Sole Source American Association of Blood Banks for Specialized Blood Products Annual Accreditation Fee Product Service Code: R499 NAICS Code: 621991 Place of Performance: Bethesda, MD 20892 POTS Number: 26-000709 Description This Notice of Intent is issued for informational purposes only and does not constitute a request for quotations. No solicitation will be issued, and quotations will not be accepted. The National Institutes of Health (NIH), Office of Purchasing and Contracts, on behalf of the Department of Transfusion Medicine, intends to award a sole source contract to: American Association of Blood Banks Inc 4550 Montgomery Avenue, Suite 700N Bethesda, Maryland 20814-3264 The purpose of this acquisition is to cover annual accreditation fees for the Department of Transfusion Medicine s accreditation assessments. Total costs will vary annually, as fees are determined by the number of accreditation types requested, the annual number of products manufactured, and the range of product types produced. Pricing listed at this time is a placeholder and will be updated upon receipt of the official invoice to reflect actual costs. Sole Source Justification The American Association of Blood Banks Inc is the only known organization authorized to assess compliance with its published standards. Accreditation through AABB is required for member organizations. Additionally, AABB provides inspection services required by HHS/CMS to obtain and maintain a certificate of compliance necessary to issue clinical test results. The Department of Transfusion Medicine s TSL and TTV sections perform and report clinical diagnostic tests that must comply with CLIA regulatory requirements. This procurement is conducted in accordance with FAR Subpart 13.106-1(b)(1), Simplified Acquisition Procedures, which permits sole source awards when only one source is reasonably available due to unique requirements. Submission Instructions Interested vendors who believe they can provide equivalent accreditation and inspection services may submit a capability statement for consideration. The Government will review all submissions to determine whether a competitive acquisition is warranted. The decision to compete this requirement remains solely at the Government s discretion. Responses Due March 5, 2026, at 6:00 AM EST Submit responses via email to: Shasheshe Goolsby Team Lead Email: shasheshe.goolsby@nih.gov Please reference POTS Number 26-000709 in all correspondence.
From Presolicitation posted on Feb 26, 2026Notice history
1-
Presolicitation LATEST Posted Feb 26, 2026
Details
Award Information
Not yet awarded
Contacts
Phone
Agency
Place of Performance
USA